New patent for United Therap drug REMODULIN

Annual Drug Patent Expirations for REMODULIN Remodulin is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are ten patents…

The post New patent for United Therap drug REMODULIN appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog